LPCAT3 Inhibitors Remodel the Polyunsaturated Phospholipid Content of Human Cells and Protect from Ferroptosis
- Journal
- ACS Chemical Biology
In The Last Decade
doi.org/10.1021/acschembio.2c00317 →Countries where authors are citing LPCAT3 Inhibitors Remodel the Polyunsaturated Phospholipid Content of Human Cells and Protect from Ferroptosis
This map shows the geographic impact of LPCAT3 Inhibitors Remodel the Polyunsaturated Phospholipid Content of Human Cells and Protect from Ferroptosis. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by LPCAT3 Inhibitors Remodel the Polyunsaturated Phospholipid Content of Human Cells and Protect from Ferroptosis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites LPCAT3 Inhibitors Remodel the Polyunsaturated Phospholipid Content of Human Cells and Protect from Ferroptosis more than expected).
Fields of papers citing LPCAT3 Inhibitors Remodel the Polyunsaturated Phospholipid Content of Human Cells and Protect from Ferroptosis
This network shows the impact of LPCAT3 Inhibitors Remodel the Polyunsaturated Phospholipid Content of Human Cells and Protect from Ferroptosis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the LPCAT3 Inhibitors Remodel the Polyunsaturated Phospholipid Content of Human Cells and Protect from Ferroptosis.
About LPCAT3 Inhibitors Remodel the Polyunsaturated Phospholipid Content of Human Cells and Protect from Ferroptosis
This paper, published in 2022, received 105 indexed citations . Written by Alex Reed, Taka-Aki Ichu, Natalia Milosevich, Bruno Melillo, Michael A. Schafroth, Yuka Otsuka, Louis Scampavia, Timothy Spicer and Benjamin F. Cravatt covering the research area of Oncology, Surgery and Cell Biology. It is primarily cited by scholars working on Pulmonary and Respiratory Medicine (85 citations), Cancer Research (68 citations) and Molecular Biology (62 citations). Published in ACS Chemical Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
This paper is also available at doi.org/10.1021/acschembio.2c00317.